Literature DB >> 21289604

Nicotine-mediated activation of dopaminergic neurons in distinct regions of the ventral tegmental area.

Rubing Zhao-Shea1, Liwang Liu, Lindsey G Soll, Ma Reina Improgo, Erin E Meyers, J Michael McIntosh, Sharon R Grady, Michael J Marks, Paul D Gardner, Andrew R Tapper.   

Abstract

Nicotine activation of nicotinic acetylcholine receptors (nAChRs) within the dopaminergic (DAergic) neuron-rich ventral tegmental area (VTA) is necessary and sufficient for nicotine reinforcement. In this study, we show that rewarding doses of nicotine activated VTA DAergic neurons in a region-selective manner, preferentially activating neurons in the posterior VTA (pVTA) but not in the anterior VTA (aVTA) or in the tail VTA (tVTA). Nicotine (1 μM) directly activated pVTA DAergic neurons in adult mouse midbrain slices, but had little effect on DAergic neurons within the aVTA. Quantification of nAChR subunit gene expression revealed that pVTA DAergic neurons expressed higher levels of α4, α6, and β3 transcripts than did aVTA DAergic neurons. Activation of nAChRs containing the α4 subunit (α4(*) nAChRs) was necessary and sufficient for activation of pVTA DAergic neurons: nicotine failed to activate pVTA DAergic neurons in α4 knockout animals; in contrast, pVTA α4(*) nAChRs were selectively activated by nicotine in mutant mice expressing agonist-hypersensitive α4(*) nAChRs (Leu9'Ala mice). In addition, whole-cell currents induced by nicotine in DAergic neurons were mediated by α4(*) nAChRs and were significantly larger in pVTA neurons than in aVTA neurons. Infusion of an α6(*) nAChR antagonist into the VTA blocked activation of pVTA DAergic neurons in WT mice and in Leu9'Ala mice at nicotine doses, which only activate the mutant receptor indicating that α4 and α6 subunits coassemble to form functional receptors in these neurons. Thus, nicotine selectively activates DAergic neurons within the pVTA through α4α6(*) nAChRs. These receptors represent novel targets for smoking-cessation therapies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21289604      PMCID: PMC3077271          DOI: 10.1038/npp.2010.240

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  47 in total

1.  Variations in desensitization of nicotinic acetylcholine receptors from hippocampus and midbrain dopamine areas.

Authors:  J A Dani; K A Radcliffe; V I Pidoplichko
Journal:  Eur J Pharmacol       Date:  2000-03-30       Impact factor: 4.432

2.  Modulation of ethanol drinking-in-the-dark by mecamylamine and nicotinic acetylcholine receptor agonists in C57BL/6J mice.

Authors:  Linzy M Hendrickson; Rubing Zhao-Shea; Andrew R Tapper
Journal:  Psychopharmacology (Berl)       Date:  2009-02-27       Impact factor: 4.530

3.  Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement.

Authors:  Cecilia Gotti; Stefania Guiducci; Vincenzo Tedesco; Silvia Corbioli; Lara Zanetti; Milena Moretti; Alessio Zanardi; Roberto Rimondini; Manolo Mugnaini; Francesco Clementi; Christian Chiamulera; Michele Zoli
Journal:  J Neurosci       Date:  2010-04-14       Impact factor: 6.167

4.  Vital signs: current cigarette smoking among adults aged >or=18 years --- United States, 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-09-10       Impact factor: 17.586

5.  Afferents to the GABAergic tail of the ventral tegmental area in the rat.

Authors:  Jennifer Kaufling; Pierre Veinante; Sophie A Pawlowski; Marie-Jose Freund-Mercier; Michel Barrot
Journal:  J Comp Neurol       Date:  2009-04-20       Impact factor: 3.215

6.  Two types of dopamine neuron distinctly convey positive and negative motivational signals.

Authors:  Masayuki Matsumoto; Okihide Hikosaka
Journal:  Nature       Date:  2009-05-17       Impact factor: 49.962

7.  Distinctive nicotinic acetylcholine receptor functional phenotypes of rat ventral tegmental area dopaminergic neurons.

Authors:  Kechun Yang; Jun Hu; Linda Lucero; Qiang Liu; Chao Zheng; Xuechu Zhen; Guozhang Jin; Ronald J Lukas; Jie Wu
Journal:  J Physiol       Date:  2008-12-01       Impact factor: 5.182

Review 8.  Mammalian nicotinic acetylcholine receptors: from structure to function.

Authors:  Edson X Albuquerque; Edna F R Pereira; Manickavasagom Alkondon; Scott W Rogers
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

9.  Dissociation between rewarding and psychomotor effects of opiates: differential roles for glutamate receptors within anterior and posterior portions of the ventral tegmental area.

Authors:  Maytal Shabat-Simon; Dino Levy; Alon Amir; Moshe Rehavi; Abraham Zangen
Journal:  J Neurosci       Date:  2008-08-20       Impact factor: 6.167

10.  Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration.

Authors:  S Pons; L Fattore; G Cossu; S Tolu; E Porcu; J M McIntosh; J P Changeux; U Maskos; W Fratta
Journal:  J Neurosci       Date:  2008-11-19       Impact factor: 6.167

View more
  55 in total

1.  Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes.

Authors:  Allison B Gold; Caryn Lerman
Journal:  Hum Genet       Date:  2012-01-31       Impact factor: 4.132

2.  Long-term nicotine treatment down-regulates α6β2* nicotinic receptor expression and function in nucleus accumbens.

Authors:  Xiomara A Perez; J Michael McIntosh; Maryka Quik
Journal:  J Neurochem       Date:  2013-10-13       Impact factor: 5.372

3.  A subset of ventral tegmental area dopamine neurons responds to acute ethanol.

Authors:  A Mrejeru; L Martí-Prats; E M Avegno; N L Harrison; D Sulzer
Journal:  Neuroscience       Date:  2015-02-07       Impact factor: 3.590

4.  Multiple CNS nicotinic receptors mediate L-dopa-induced dyskinesias: studies with parkinsonian nicotinic receptor knockout mice.

Authors:  Maryka Quik; Carla Campos; Sharon R Grady
Journal:  Biochem Pharmacol       Date:  2013-07-04       Impact factor: 5.858

5.  Mesolimbic dopamine and habenulo-interpeduncular pathways in nicotine withdrawal.

Authors:  John A Dani; Mariella De Biasi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-06-01       Impact factor: 6.915

6.  Mutually augmenting interactions of dextromethorphan and sazetidine-A for reducing nicotine self-administration in rats.

Authors:  Edward D Levin; Corrine Wells; Susan Slade; Amir H Rezvani
Journal:  Pharmacol Biochem Behav       Date:  2018-01-31       Impact factor: 3.533

7.  Expression profile of nicotinic acetylcholine receptor subunits in the brain of HIV-1 transgenic rats given chronic nicotine treatment.

Authors:  Junran Cao; Tanseli Nesil; Shaolin Wang; Sulie L Chang; Ming D Li
Journal:  J Neurovirol       Date:  2016-04-07       Impact factor: 2.643

8.  Functional Upregulation of α4* Nicotinic Acetylcholine Receptors in VTA GABAergic Neurons Increases Sensitivity to Nicotine Reward.

Authors:  Jennifer Ngolab; Liwang Liu; Rubing Zhao-Shea; Guangping Gao; Paul D Gardner; Andrew R Tapper
Journal:  J Neurosci       Date:  2015-06-03       Impact factor: 6.167

Review 9.  Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders.

Authors:  Maryka Quik; Xiomara A Perez; Sharon R Grady
Journal:  Biochem Pharmacol       Date:  2011-06-13       Impact factor: 5.858

10.  Selective breeding for high alcohol preference increases the sensitivity of the posterior VTA to the reinforcing effects of nicotine.

Authors:  Sheketha R Hauser; Amy L Bracken; Gerald A Deehan; Jamie E Toalston; Zheng-Ming Ding; William A Truitt; Richard L Bell; William J McBride; Zachary A Rodd
Journal:  Addict Biol       Date:  2013-03-18       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.